ATOSSA THERAPEUTICS, INC. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6dcb20b0-34d7-48e7-8019-3677adbea411/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-34.8M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-124396 |
| FY 2024 | $-25.5M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-044099 |
| FY 2023 | $-30.1M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-039306 |
| FY 2022 | $-27.0M | 2022-01-01 – 2022-12-31 | evidence 0001437749-23-007531 |
| FY 2021 | $-20.6M | 2021-01-01 – 2021-12-31 | evidence 0001437749-22-004614 |
| FY 2020 | $-17.8M | 2020-01-01 – 2020-12-31 | evidence 0001437749-22-004614 |
| FY 2019 | $-17.2M | 2019-01-01 – 2019-12-31 | evidence 0001437749-20-006155 |
| FY 2018 | $-11.4M | 2018-01-01 – 2018-12-31 | evidence 0001437749-19-005927 |
| FY 2017 | $-8.1M | 2017-01-01 – 2017-12-31 | evidence 0001615774-18-003668 |
| FY 2016 | $-6.4M | 2016-01-01 – 2016-12-31 | evidence 0001615774-17-001088 |
| FY 2015 | $-15.8M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-091380 |
| FY 2014 | $-14.7M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-019344 |
| FY 2013 | $-22.9M | 2009-04-30 – 2014-03-31 | evidence 0001144204-14-030427 |
| FY 2012 | $-11.7M | 2009-04-30 – 2013-03-31 | evidence 0001144204-13-029094 |
| FY 2011 | $-3.4M | 2011-01-01 – 2011-12-31 | evidence 0001144204-14-018247 |
| FY 2010 | $-1.1M | 2010-01-01 – 2010-12-31 | evidence 0001144204-13-018024 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ATOSSA THERAPEUTICS, INC. — all facts · Revenue · Operating Income